In the News…Ozempic Face (Semaglutide weight loss and what to do about it)

 

 

Semaglutide is a medication that has been approved by the FDA for use in the treatment of obesity. The drug is a GLP-1 receptor agonist, which means that it works by mimicking the effects of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1).

When a person eats a meal, GLP-1 is released from the intestines and acts on the pancreas to stimulate insulin secretion, which helps to regulate blood sugar levels. GLP-1 also acts on the brain to reduce appetite and promote feelings of fullness.

Semaglutide works in a similar way to GLP-1, but it is a longer-acting medication that can remain in the body for up to a week after a single dose. By activating the GLP-1 receptors, Semaglutide can help to reduce food intake, increase feelings of fullness, and ultimately lead to weight loss.

Specifically, Semaglutide helps to reduce appetite by acting on the area of the brain that controls hunger and satiety. It also slows down the emptying of the stomach, which can help to reduce the amount of food a person eats at a given meal.

In clinical trials, Semaglutide has been shown to be highly effective for weight loss. In one study, participants who took Semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared to just 2.4% for those who took a placebo.

Overall, Semaglutide represents a promising new treatment option for obesity, which can help people achieve significant weight loss and improve their overall health. However, like any medication, it is important to work closely with a healthcare provider to ensure that it is safe and effective for an individual’s unique needs.